Physician profile
David Lopez
NPI 1629021399
$5,431.00
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,405 · 2020: $156 · 2021: $289 · 2022: $1,227 · 2023: $209 · 2024: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $353.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $4,265.00 | 2019-2022 | |
| Stryker Corporation | $599.88 | 2019-2024 | Salvation, Inspace |
| Smith+Nephew, INC. | $133.37 | 2019 | |
| Davol INC. | $119.66 | 2023 | Channel Drain |
| Dynasplint Systems INC. | $65.68 | 2023 | Dynasplint |
| Encore Medical, LP | $61.25 | 2021 | |
| Medacta USA, INC. | $43.00 | 2024 | |
| Intellijoint Surgical INC. | $38.01 | 2019-2021 | |
| Linvatec Corporation | $23.70 | 2023 | Biobrace 23mm |
| Zimmer Biomet Holdings, INC. | $22.52 | 2021 | |
| Abbott Laboratories | $18.49 | 2024 | Proclaim |
| Seapearl East, INC | $13.80 | 2022 | |
| Horizon Therapeutics Plc | $13.41 | 2022 | |
| Bioventus LLC | $13.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.